Found 37 matching trials
Genetic Study of Immunodeficiency: Search for New Genetic Causes for Primary Immunodeficiencies
N/AIndividuals with suspected primary immunodeficiency will be studied and the...
Location
Division of Immunology
Investigating the Role of Genetics in Disease Predisposition
N/AGametogenesis is the production of sperm and eggs; it takes place through t...
Status
Enrolling By Invitation
Location
Wellcome Sanger Institute
Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
N/AThis protocol serves as a mechanism to collect, store, and distribute bodil...
Location
University of Minnesota Masonic Cancer Center
Tissue Repository: CTCL Collection Protocol
N/AThis document is a protocol for a non-interventional human research study i...
Location
Columbia University Irving Medical Center
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NAThis clinical trial tests next generation sequencing (NGS) for the detectio...
Location
Mayo Clinic in Arizona
Establishment of a Biobank for the Evaluation of Rapid Diagnostic Solutions
N/AThis multicenter prospective registry aims to establish a biobank of residu...
Bioclinical Study of Scalp Photoaging of a Population Male Over 65 Years Old.
NAThe aging of skin, especially that of the scalp, is a combination of intrin...
Location
Chu de Saint Etienne
Staphylococcus Aureus in Atopic Dermatitis Immunopathology
NAAtopic Dermatitis (AD) is a frequent inflammatory skin disease characterize...
Location
Centre Hospitalier Lyon Sud
Treatments Being Tested
Blood sample (Day -42 to Day -28, Day 3),Skin swab sampling (Day -42 to Day -28, Day 0, Day 13) , patch test application (Day 0) , skin biopsies (Day 13)Blood sample (Day 0 ,Day 3),Skin swab sampling (Day 0,Day 13), patch test application (Day 1), skin biopsies (Day 13) Predictive Clinical and Biological Parameters in Acute Leukemia, Myelodysplastic Syndromes and Myeloproliferative Disorders-HEMATO-BIO-IPC-2013-015
NAHEMATO-BIO-IPC-2013-015 is a monocenter prospective longitudinal study. Our...
Location
Institut Paoli-Calmettes
CPX-351 (Vyxeosâą) for Transplant Eligible, Higher Risk Patients With Myelodysplastic Syndrome
PHASE1This is a pilot and feasibility study of transplant eligible, higher risk m...
Status
Active Not Recruiting
Location
Moffitt Cancer Center